Byong Duk Ye

A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia

Suk‐Kyun Yang, Myunghee Hong, Jiwon Baek et al. · Nature Genetics · 2014 · 547 citations · Full text

Medicine, Hematology, Pharmacology +7

Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

Stefan Schreiber, Shomron Ben‐Horin, Jarosław Leszczyszyn et al. · Gastroenterology · 2021 · 227 citations

Pharmacy, Immunology, Pharmacotherapy +13

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Zhanju Liu, Ruize Liu, Han Gao et al. · Nature Genetics · 2023 · 218 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Byong Duk Ye, Marina Pesegova, Olga Alexeeva et al. · The Lancet · 2019 · 209 citations · Full text

Medicine, Clinical Sciences, Immunology +11

Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations

Suk‐Kyun Yang, Myunghee Hong, Wanting Zhao et al. · Gut · 2013 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17